Federal officials this month opened an investigation into another infant death that may be linked to Abbott Laboratories — the nation’s largest baby formula maker.
The baby died in January and had “consumed an Abbott product,” the Food and Drug Administration said Wednesday, citing a consumer complaint sent to the agency in February.
The FDA was made aware of the complaint on June 10.
“The investigation into this latest consumer complaint is in its early stages and the agency will provide an update as soon as it learns more,” the agency wrote in a statement.
It was unclear what product the baby was consuming or if it was tied to the Abbott Laboratories plant, which closed in February amid a spate of bacterial infections, compounding a nationwide shortage of formulas that began during the pandemic
Abbott’s Sturgis, Michigan plant was closed and recalls were launched after the FBI investigated four infections in infants fed the formula made at the plant. Two of the babies died from the rare infections.
Abbott reopened the plant earlier this month after the FDA could not positively link the diseases to the company that makes Similac. The FBI found numerous violations at the facility, including poor sanitation and safety procedures.
“While we must take action to address the FDA’s observations, it is important to note that no Cronobacter sakazakii or salmonella was found in one of our tests of products distributed to consumers,” the company said last month.
The FDA had previously investigated 128 complaints, including nine deaths, that may have been related to Abbott formulas, but was only able to link four of them to the nutritional company.
Abbott Laboratories shares rose about 1% on Wednesday after the FDA disclosure.
https://nypost.com/2022/06/22/fda-investigating-another-baby-death-possibly-tied-to-abbott-formula/ The FDA is investigating another baby death that may be linked to the Abbott formula